Vivek Y. Reddy, MD, Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories
Vivek Y. Reddy, MD, and his team bring innovation to The Mount Sinai Medical Center Electrophysiology Laboratories.
Vivek Y. Reddy, M.D., one of the nation’s leading cardioelectrophysiologists, has joined The Mount Sinai Medical Center as Director of Electrophysiology Laboratories. His appointment becomes effective July 1.
Dr. Reddy leads a team of physician-scientists who are developing definitive therapies for cardiac arrhythmias – including atrial fibrillation, the most common abnormal heart rhythm affecting millions of Americans, and ventricular tachycardias, the most common cause of sudden cardiac death – with the intent of eliminating the need for chronic medications. Dr. Reddy’s efforts include fundamental research on the role of imaging modalities (MRI, CT, Ultrasound) to guide cardiac electrophysiology procedures.
Mount Sinai Heart is committed to developing groundbreaking therapies for cardiac patients. The appointments of Dr. Reddy and his team demonstrate that we will continue to seek out the greatest talent available to improve our services, said Valentin Fuster, M.D,. Ph.D., Director of Mount Sinai Heart.
Dr. Reddy’s team specializes in cutting-edge clinical and translational research and have conducted many "first-in-man" studies of novel technologies, including the first use of a balloon cryoablation catheter to treat atrial fibrillation, and the first use of an endoscopic balloon ablation catheter to visually guide ablation of atrial fibrillation. In 2003, he led the team that performed the first image-guided-therapy procedures in cardiac electrophysiology, using pre-acquired three-dimensional CT/MR images of the heart to guide catheter ablation of atrial fibrillation.
He has published numerous articles, most famously a seminal multi-center clinical trial on ventricular tachycardia ablation. Known as SMASH-VT (Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia), the study examined the use of prophylactic catheter ablation to prevent shocks in patients receiving defibrillators. The findings from SMASH-VT were published in the New England Journal of Medicine.
Dr. Reddy was most recently Director of Cardiac Electrophysiology and Associate Professor of Medicine at the University of Miami, Miller School of Medicine. There he helped build a world-class cardiovascular team specializing in heart rhythm disorders. Prior to that, Dr. Reddy worked at Massachusetts General Hospital in Boston for seven years, serving as Director of the Experimental Electrophysiology Laboratory. Since 2001, he also served as Instructor of Medicine at Harvard Medical School. Dr. Reddy has received numerous honors including the Center for Minimally Invasive Therapy Fellowship and the Howard Hughes Medical Institute Scholarship. Dr. Reddy’s team includes Andre d'Avila, MD, PhD, and Srinivas R. Dukkipati, MD, who will also be joining Mount Sinai.
Dr. Reddy has also served since 2005 as a Co-Director of the Annual Boston Atrial Fibrillation Symposium, and he founded and has directed since 2006 the Annual International Symposium on Ventricular Arrhythmias. Dr. Reddy has been the Director of Experimental Electrophysiology at Massachusetts General Hospital, a teaching affiliate of Harvard Medical School.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic-science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Mount Sinai Launches Cardiac Catheterization Artificial Intelligence Research Lab
Sep 15, 2025 View All Press Releases
Mount Sinai Surgeons Perform First Heart-Liver-Kidney Transplants in New York State
May 20, 2025 View All Press Releases
